Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients

Kiziltan H. S., TAŞTEKİN D., ERİŞ A. H., Taspinar O., Ismaylova M., MAYADAĞLI A.

BEZMIALEM SCIENCE, vol.4, no.2, pp.51-55, 2016 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 4 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.14235/bs.2016.467
  • Journal Name: BEZMIALEM SCIENCE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.51-55
  • Keywords: Small cell lung cancer, chemoradiotherapy, vena cava syndrome, CISPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, CARCINOMA, IRRADIATION, COMBINATION, DOXORUBICIN
  • Istanbul University Affiliated: Yes

Abstract

Objective: We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at different clinics for SCLC compared to the treatment results at a clinic.